The natural history of sclerosteosis
- PMID: 12694228
- DOI: 10.1034/j.1399-0004.2003.00036.x
The natural history of sclerosteosis
Erratum in
- Clin Genet. 2003 Aug;64(2):176
Abstract
Sclerosteosis (SCL) is a severe, progressive, autosomal-recessive craniotubular hyperostosis (MIM 269500). The determinant gene (SOST) has been isolated, and genotype-phenotype correlations, as well as the elucidation of pathogenetic mechanisms, are dependent upon the documentation of the natural history of the condition. For this reason, the course and complications in 63 affected individuals in South Africa, seen over a 38-year period, have been analyzed. Thirty-four of these persons died during the course of the survey, 24 from complications related to elevation of intracranial pressure as a result of calvarial overgrowth. The mean age of death in this group of individuals was 33 years, with an even gender distribution. Facial palsy and deafness, as a result of cranial nerve entrapment, developed in childhood in 52 (82%) affected persons. Mandibular overgrowth was present in 46 (73%) adults and syndactyly in 48 (76%). In South Africa in 2002, 29 affected persons were alive, 10 being < or =20 years of age. It is evident that sclerosteosis is a severe disorder which places a considerable burden upon affected individuals and their families.
Copyright Blackwell Munksgaard, 2003
Similar articles
-
SOST-Related Sclerosing Bone Dysplasias.2002 Jun 4 [updated 2024 Aug 1]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. 2002 Jun 4 [updated 2024 Aug 1]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 36508511 Free Books & Documents. Review.
-
Genetics of Sost/SOST in sclerosteosis and van Buchem disease animal models.Metabolism. 2018 Mar;80:38-47. doi: 10.1016/j.metabol.2017.10.005. Epub 2017 Oct 25. Metabolism. 2018. PMID: 29080811 Review.
-
A known SOST gene mutation causes sclerosteosis in a familial and an isolated case from Brazilian origin.Genet Test. 2008 Dec;12(4):475-9. doi: 10.1089/gte.2008.0036. Genet Test. 2008. PMID: 19072561
-
Novel SOST gene mutation in a sclerosteosis patient from Morocco: a case report.Eur J Med Genet. 2014 Mar;57(4):133-7. doi: 10.1016/j.ejmg.2014.02.007. Epub 2014 Mar 1. Eur J Med Genet. 2014. PMID: 24594238
-
Sclerosteosis - an autosomal recessive disorder.Clin Genet. 1977 Jan;11(1):1-7. doi: 10.1111/j.1399-0004.1977.tb01269.x. Clin Genet. 1977. PMID: 187366
Cited by
-
Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease.Genome Res. 2005 Jul;15(7):928-35. doi: 10.1101/gr.3437105. Epub 2005 Jun 17. Genome Res. 2005. PMID: 15965026 Free PMC article.
-
The Role of Sclerostin in Bone Diseases.J Clin Med. 2022 Feb 2;11(3):806. doi: 10.3390/jcm11030806. J Clin Med. 2022. PMID: 35160258 Free PMC article. Review.
-
Characterization of the structural features and interactions of sclerostin: molecular insight into a key regulator of Wnt-mediated bone formation.J Biol Chem. 2009 Apr 17;284(16):10890-900. doi: 10.1074/jbc.M807994200. Epub 2009 Feb 10. J Biol Chem. 2009. PMID: 19208630 Free PMC article.
-
Parathyroid hormone signaling in mature osteoblasts/osteocytes protects mice from age-related bone loss.Aging (Albany NY). 2021 Dec 30;13(24):25607-25642. doi: 10.18632/aging.203808. Epub 2021 Dec 30. Aging (Albany NY). 2021. PMID: 34968192 Free PMC article.
-
The clinical potential of romosozumab for the prevention of fractures in postmenopausal women with osteoporosis.Ther Adv Musculoskelet Dis. 2018 Jun;10(5-6):105-115. doi: 10.1177/1759720X18775936. Epub 2018 Jun 7. Ther Adv Musculoskelet Dis. 2018. PMID: 29942362 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous